Not Medicare Enrolled
Dr. Ram Garg, MD
Neurology · Taylor, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Garg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Garg
Dr. Ram Garg is a neurology specialist in Taylor, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Garg performed 5,683 Medicare services across 1,163 unique beneficiaries.
Between the years covered by Open Payments, Dr. Garg received a total of $159,143 from 71 pharmaceutical and/or device companies across 1835 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Garg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in MI
$159,143 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,683
Medicare services
Top 6% in MI for neurology
1,163
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~284 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,549 | $95 | $176 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
1,434 | $4 | $20 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
818 | $63 | $80 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
713 | $12 | $20 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
240 | $105 | $200 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
190 | $15 | $20 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
187 | $51 | $100 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
176 | $16 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $119 | $220 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
67 | $120 | $190 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
64 | $78 | $150 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
59 | $44 | $300 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
39 | $271 | $650 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
32 | $169 | $400 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
24 | $198 | $440 |
| Epidural steroid injection A continuous infusion of an anesthetic agent is injected into the lower back nerve bundle to provide pain relief. |
20 | $40 | $301 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.4% high complexity
27.7% medium
65.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$159,143
Total received (2018-2024)
Avg $22,735/year across 7 years
Top 7% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
1,835
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$122,481 (77.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,272 (13.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,390 (9.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,160
2023
$12,065
2022
$27,661
2021
$20,411
2020
$22,553
2019
$25,060
2018
$48,232
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$520
Biogen, Inc.
$366
EMD Serono, Inc.
$231
ABBVIE INC.
$225
Neurocrine Biosciences, Inc.
$190
CATALYST PHARMACEUTICALS, INC.
$182
Novartis Pharmaceuticals Corporation
$164
Teva Pharmaceuticals USA, Inc.
$140
Neurelis, Inc.
$123
JAZZ PHARMACEUTICALS INC.
$117
ARGENX US, INC.
$96
PFIZER INC.
$94
SK Life Science, Inc.
$93
MITSUBISHI TANABE PHARMA AMERICA, INC.
$84
Kyowa Kirin, Inc.
$71
Axsome Therapeutics, Inc.
$53
Amneal Pharmaceuticals LLC
$48
Lundbeck LLC
$45
Sumitomo Pharma America, Inc.
$44
Genentech USA, Inc.
$40
Eisai Inc.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$36
Lilly USA, LLC
$34
LivaNova USA, Inc.
$28
AstraZeneca Pharmaceuticals LP
$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Alexion Pharmaceuticals, Inc.
$20
Celgene Corporation
$17
Amgen Inc.
$17
Top 3 companies account for 35.4% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$28,864
EISAI INC.
$22,003
Teva Pharmaceuticals USA, Inc.
$16,647
ABBVIE INC.
$15,197
Eisai Inc.
$12,302
AbbVie Inc.
$11,606
Allergan, Inc.
$11,249
SK Life Science, Inc.
$9,161
Bayer HealthCare Pharmaceuticals Inc.
$5,002
UCB, Inc.
$4,489
Sunovion Pharmaceuticals Inc.
$3,457
Biogen, Inc.
$2,854
Catalyst Pharmaceuticals, Inc.
$2,323
Novartis Pharmaceuticals Corporation
$2,242
Supernus Pharmaceuticals, Inc.
$1,225
EMD Serono, Inc.
$1,055
Neurocrine Biosciences, Inc.
$972
Amgen Inc.
$609
Takeda Pharmaceuticals U.S.A., Inc.
$519
Neurelis, Inc.
$484
Lilly USA, LLC
$426
Celgene Corporation
$408
US WorldMeds, LLC
$399
Adamas Pharmaceuticals, Inc.
$384
PFIZER INC.
$365
Genentech USA, Inc.
$363
Lundbeck LLC
$343
JAZZ PHARMACEUTICALS INC.
$335
ARGENX US, INC.
$275
Kyowa Kirin, Inc.
$229
CATALYST PHARMACEUTICALS, INC.
$221
Avanir Pharmaceuticals, Inc.
$208
MDD US Operations, LLC
$195
Amneal Pharmaceuticals LLC
$194
Corium, LLC
$180
Axsome Therapeutics, Inc.
$178
Horizon Therapeutics plc
$171
Alexion Pharmaceuticals, Inc.
$153
Biohaven Pharmaceutical Holding Company Ltd.
$136
MITSUBISHI TANABE PHARMA AMERICA, INC.
$126
Allergan Inc.
$125
Sumitomo Pharma America, Inc.
$120
AQUESTIVE THERAPEUTICS, INC.
$116
LivaNova USA, Inc.
$109
ITI, Inc.
$105
Acorda Therapeutics, Inc
$96
Biohaven Pharmaceuticals, Inc.
$80
AstraZeneca Pharmaceuticals LP
$76
Mitsubishi Tanabe Pharma America, Inc.
$71
Greenwich Biosciences, Inc.
$64
Janssen Pharmaceuticals, Inc
$64
OWP Pharmaceuticals, Inc.
$61
Zogenix Inc.
$61
Otsuka America Pharmaceutical, Inc.
$52
Harmony Biosciences LLC
$50
ACADIA Pharmaceuticals Inc
$38
E.R. Squibb & Sons, L.L.C.
$38
Bausch Health US, LLC
$31
HARMONY BIOSCIENCES LLC
$30
Impax Laboratories, Inc.
$29
IMPEL PHARMACEUTICALS INC.
$24
TG THERAPEUTICS, INC.
$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Banner Life Sciences, LLC
$19
Jazz Pharmaceuticals Inc.
$16
Egalet US Inc
$16
Vanda Pharmaceuticals Inc.
$16
Promius Pharma LLC
$15
Mylan Pharmaceuticals Inc.
$14
Merck Sharp & Dohme Corporation
$12
SANOFI-AVENTIS U.S. LLC
$3
Top 3 companies account for 42.4% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · Auvelity · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CAPLYTA · CHANTIX · COMIRNATY · COPAXONE · Cenobamate · DUOPA · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Glatiramer Acetate · Hetlioz · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LUMIZYME · LYRICA · Lamotrigine Starter Kit · Leqembi · Lucemyra/Lofexidine · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · Ocrevus · Ongentys · PLEGRIDY · POMPE - DISEASE · PRALUENT · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · Soliris · Subvenite · TECFIDERA · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · UZEDY · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Vyvanse · Wakix · XADAGO · XARELTO · XCOPRI · Xadago · ZEPOSIA · ZINBRYTA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for neurology in MI.
Geographic Context
Neurologists within 10 mi
326
Per 100K population
18.4
County median income
$59,521
Nearest hospital
BEAUMONT HOSPITAL - TAYLOR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Garg is a clinical cardiology specialist, with above-average Medicare volume (top 6% in MI), with speaking/promotional industry engagement in the top 7% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Garg experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Garg performed 1,549 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garg receive payments from pharmaceutical companies?
Yes. Dr. Garg received a total of $159,143 from 71 companies across 1,835 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garg's costs compare to other neurologists in Taylor?
Dr. Garg's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Taylor
Browse neurologists in Taylor ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
EISAI INC. Payments to Doctors
See all physicians who received payments from EISAI INC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology